RECORDATI: CONTINUING THE JOURNEY OF PROFITABLE GROWTH
September 2023
AGENDA
Recordati today, strategy and value proposition
- Recordati today
- Strategy and 2023-2025 Financial projections
Two core businesses
- Specialty & Primary Care
- Rare diseases
2023 first half results and FY 2023 guidance
AGENDA
Recordati today, strategy and value proposition
- Recordati today
- Strategy and 2023-2025 Financial projections
Two core businesses
- Specialty & Primary Care
- Rare diseases
2023 first half results and FY 2023 guidance
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Recordati Industria Chimica e Farmaceutica S.p.A. published this content on 08 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 September 2023 08:01:06 UTC.